U.S. Cannabis Stocks Swoon As Mitch McConnell Throws Cold Water On SAFE Banking Amendment

U.S. cannabis stocks, as reflected in AdvisorShares Pure US Cannabis ETF MSOS, sank on Tuesday as hoped-for regulatory reform hit a snafu in Congress. Specifically, the inclusion of a cannabis-focused amendment in the National Defense Authorization Act (NDAA) appears unlikely, as an old nemesis is once again raising objections.

McConnell throws cold water on marijuana banking or permitting reform being included in NDAA “If Democrats wanted these controversial items so badly, they had two years to move them across the floor”

— Burgess Everett (@burgessev) December 6, 2022

 

Over the past week, investors had been bidding up cannabis stocks on hopes that the SAFE Banking Act, which sponsor Rep. Ed Perlmutter attached to the NDAA in July, would make the final cut for the must-pass annual defense appropriation bill. As it were, Senate Minority Leader Mitch McConnell is fighting against its inclusion, arguing that passing SAFE Banking would “mak(e) our financial system more sympathetic to illegal drugs.” Full quote in context below:

"House and Senate Democrats are still obstructing efforts to close out the NDAA by trying to jam in unrelated items with no relationship whatsoever to defense,” McConnell said on the floor on Tuesday. We’re talking about a grab bag of miscellaneous pet priorities—making our financial system more sympathetic to illegal drugs or the phony, partisan permitting reform and name-only language that’s already failed to pass the Senate earlier this year."

The Kentucky Republican’s criticism isn’t a good sign for SAFE Banking’s prospects for passage in the NDAA, as support from Congressional leadership is critical for SAFE’s inclusion into the final bill. Although, ten GOP senators could still break ranks and vote in favor of the package, this is not the path of least resistance.

The opposition on SAFE Banking is nothing new for Mitch McConnell, who has consistently blocked any attempt for federal reform as Senate Majority Leader under the Trump administration.

More recently, McConnell called out Democrats earlier this year when SAFE Banking was attached to the House version of the America COMPETES Act, saying that Democrats, “goes out of its way to include provisions on, listen to this, marijuana banking.”

Undaunted, President Biden signed the CHIPS and Science Act later that summer, comprised largely of provisions extracted from the US Innovation and Competition Act and its House alternative, the aforementioned America COMPETES Act.

Should SAFE Banking fail to make it in as an amendment to the NDAA, it could be pushed into fiscal 2023 omnibus negotiations. After weeks of inaction, top appropriators and congressional leaders began making headway on a bipartisan deal that would pave the way for an overdue omnibus spending package, although formidable sticking points remain.

On Tuesday, U.S. cannabis stocks as reflected through MSOS ETF fell 12.84%, falling just shy of the 11.44 million shares traded on the Monday session. Canadian licensed producers declined with equivalent force, with Canopy Growth (CGC) and Tilray Brands (TLRY) falling 16.44% and 13.25%, respectively.

This article was originally published on The Dales Report and appears here with permission.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisMarketscontributors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.